JG
INDV icon

Joel Greenblatt’s Indivior Pharmaceuticals INDV Stock Holding History

Joel Greenblatt’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89M Sell
94,850
-76,625
-45% -$2.78M 0.01% 1006
2026
Q1 		$5.23M Buy
171,475
+162,325
+1,774% +$5.36M 0.02% 858
2025
Q4 		$328K Sell
9,150
-6,654
-42% -$203K ﹤0.01% 1544
2025
Q3 		$381K Buy
+15,804
New +$331K ﹤0.01% 1449
2025
Q1 		– Sell
-26,121
Closed -$325K – 1611
2024
Q4 		$325K Buy
+26,121
New +$269K ﹤0.01% 1241

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Joel Greenblatt's INDV Position: Q2 2026 in Review

Joel Greenblatt reduced its Indivior Pharmaceuticals (INDV) stake by 45% in Q2 2026, selling an estimated $2.78M and leaving 94,850 shares worth $3.89M. The position accounts for 0.01% of the portfolio, ranked #1006.

Joel Greenblatt first reported a position in INDV in Q4 2024 and has held it in 5 quarters since. The position peaked at $5.23M in Q1 2026. 335 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Joel Greenblatt held 94,850 shares of Indivior Pharmaceuticals worth $3.89M as of Q2 2026.
  • Joel Greenblatt sold 76,625 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.78M.
  • Indivior Pharmaceuticals made up 0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1006 holding.
  • Joel Greenblatt first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Joel Greenblatt's Indivior Pharmaceuticals position peaked at $5.23M in Q1 2026.
  • 335 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.